Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
22.01. | AFT Pharmaceuticals - Another R&D asset in the bag | 282 | Edison Investment Research | AFT Pharmaceuticals has announced the addition of another candidate, HY-091, to its R&D pipeline, for the management of vulvar lichen sclerosus (VLS), a skin condition with no curative treatments available.... ► Artikel lesen | |
22.01. | Accsys Technologies - Updating estimates for guidance and capital raise | 391 | Edison Investment Research | In September 2023, Accsys warned of weaker market conditions in the building materials and construction markets and in November, it stated not to expect trading conditions to improve materially until... ► Artikel lesen | |
22.01. | OSE Immunotherapeutics - Active year ahead for proprietary programmes | 342 | Edison Investment Research | OSE has refreshed its outlook for 2024, including the commencement of the confirmatory Phase III trial for lead asset Tedopi (an off-the-shelf, neoepitope-based cancer vaccine) in second-line non-small... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 1.560 |
NEL | 1.055 |
BAYER | 935 |
TUI | 761 |
BYD | 675 |
DEUTSCHE BANK | 656 |
RWE | 597 |
MERCEDES-BENZ | 594 |
NVIDIA | 574 |
RHEINMETALL | 525 |
PLUG POWER | 507 |
SUPER MICRO COMPUTER | 495 |
TESLA | 465 |
BIONTECH | 437 |
DEUTSCHE LUFTHANSA | 433 |
AIXTRON SE | 431 |
VOLKSWAGEN | 404 |
RENK GROUP | 390 |
COMMERZBANK | 377 |
PALANTIR TECHNOLOGIES | 374 |
ALLIANZ | 373 |
SIEMENS ENERGY | 364 |
VARTA | 364 |
THYSSENKRUPP | 359 |
BASF | 357 |